BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

599 related articles for article (PubMed ID: 8664253)

  • 1. Kinetics of nonenzymatic glycation of ribonuclease A leading to advanced glycation end products. Paradoxical inhibition by ribose leads to facile isolation of protein intermediate for rapid post-Amadori studies.
    Khalifah RG; Todd P; Booth AA; Yang SX; Mott JD; Hudson BG
    Biochemistry; 1996 Apr; 35(15):4645-54. PubMed ID: 8664253
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro kinetic studies of formation of antigenic advanced glycation end products (AGEs). Novel inhibition of post-Amadori glycation pathways.
    Booth AA; Khalifah RG; Todd P; Hudson BG
    J Biol Chem; 1997 Feb; 272(9):5430-7. PubMed ID: 9038143
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Amadorins: novel post-Amadori inhibitors of advanced glycation reactions.
    Khalifah RG; Baynes JW; Hudson BG
    Biochem Biophys Res Commun; 1999 Apr; 257(2):251-8. PubMed ID: 10198198
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thiamine pyrophosphate and pyridoxamine inhibit the formation of antigenic advanced glycation end-products: comparison with aminoguanidine.
    Booth AA; Khalifah RG; Hudson BG
    Biochem Biophys Res Commun; 1996 Mar; 220(1):113-9. PubMed ID: 8602828
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relative quantification of N(epsilon)-(Carboxymethyl)lysine, imidazolone A, and the Amadori product in glycated lysozyme by MALDI-TOF mass spectrometry.
    Kislinger T; Humeny A; Peich CC; Zhang X; Niwa T; Pischetsrieder M; Becker CM
    J Agric Food Chem; 2003 Jan; 51(1):51-7. PubMed ID: 12502384
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glycation, glycoxidation, and cross-linking of collagen by glucose. Kinetics, mechanisms, and inhibition of late stages of the Maillard reaction.
    Fu MX; Wells-Knecht KJ; Blackledge JA; Lyons TJ; Thorpe SR; Baynes JW
    Diabetes; 1994 May; 43(5):676-83. PubMed ID: 8168645
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Formation of reactive intermediates from Amadori compounds under physiological conditions.
    Zyzak DV; Richardson JM; Thorpe SR; Baynes JW
    Arch Biochem Biophys; 1995 Jan; 316(1):547-54. PubMed ID: 7840665
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glycation of human cortical and cancellous bone captures differences in the formation of Maillard reaction products between glucose and ribose.
    Sroga GE; Siddula A; Vashishth D
    PLoS One; 2015; 10(2):e0117240. PubMed ID: 25679213
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Advanced glycation end product ligands for the receptor for advanced glycation end products: biochemical characterization and formation kinetics.
    Valencia JV; Weldon SC; Quinn D; Kiers GH; DeGroot J; TeKoppele JM; Hughes TE
    Anal Biochem; 2004 Jan; 324(1):68-78. PubMed ID: 14654047
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glycation of Ribonuclease A affects its enzymatic activity and DNA binding ability.
    Dinda AK; Tripathy DR; Dasgupta S
    Biochimie; 2015 Nov; 118():162-72. PubMed ID: 26365067
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Amadori product and age formation during nonenzymatic glycosylation of bovine serum albumin in vitro.
    Sharma SD; Pandey BN; Mishra KP; Sivakami S
    J Biochem Mol Biol Biophys; 2002 Aug; 6(4):233-42. PubMed ID: 12186738
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The pyridoxamine action on Amadori compounds: A reexamination of its scavenging capacity and chelating effect.
    Adrover M; Vilanova B; Frau J; Muñoz F; Donoso J
    Bioorg Med Chem; 2008 May; 16(10):5557-69. PubMed ID: 18434162
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Age-related accumulation of Maillard reaction products in human articular cartilage collagen.
    Verzijl N; DeGroot J; Oldehinkel E; Bank RA; Thorpe SR; Baynes JW; Bayliss MT; Bijlsma JW; Lafeber FP; Tekoppele JM
    Biochem J; 2000 Sep; 350 Pt 2(Pt 2):381-7. PubMed ID: 10947951
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aged garlic extract and S-allyl cysteine prevent formation of advanced glycation endproducts.
    Ahmad MS; Pischetsrieder M; Ahmed N
    Eur J Pharmacol; 2007 Apr; 561(1-3):32-8. PubMed ID: 17321518
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Physicochemical analysis of structural alteration and advanced glycation end products generation during glycation of H2A histone by 3-deoxyglucosone.
    Ashraf JM; Ahmad S; Rabbani G; Jan AT; Lee EJ; Khan RH; Choi I
    IUBMB Life; 2014 Oct; 66(10):686-93. PubMed ID: 25380060
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modification of proteins in vitro by physiological levels of glucose: pyridoxamine inhibits conversion of Amadori intermediate to advanced glycation end-products through binding of redox metal ions.
    Voziyan PA; Khalifah RG; Thibaudeau C; Yildiz A; Jacob J; Serianni AS; Hudson BG
    J Biol Chem; 2003 Nov; 278(47):46616-24. PubMed ID: 12975371
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nitric oxide inhibits the formation of advanced glycation end products.
    Asahi K; Ichimori K; Nakazawa H; Izuhara Y; Inagi R; Watanabe T; Miyata T; Kurokawa K
    Kidney Int; 2000 Oct; 58(4):1780-7. PubMed ID: 11012913
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 2'-Deoxyribose Mediated Glycation Leads to Alterations in BSA Structure Via Generation of Carbonyl Species.
    Rafi Z; Alouffi S; Khan MS; Ahmad S
    Curr Protein Pept Sci; 2020; 21(9):924-935. PubMed ID: 32053073
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ilex paraguariensis extracts inhibit AGE formation more efficiently than green tea.
    Lunceford N; Gugliucci A
    Fitoterapia; 2005 Jul; 76(5):419-27. PubMed ID: 15894431
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Age-related decrease in proteoglycan synthesis of human articular chondrocytes: the role of nonenzymatic glycation.
    DeGroot J; Verzijl N; Bank RA; Lafeber FP; Bijlsma JW; TeKoppele JM
    Arthritis Rheum; 1999 May; 42(5):1003-9. PubMed ID: 10323457
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.